ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 22 December to 28 December 2025

The 10 most important of the 94 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Rheumatology · Ann Rheum Dis · 2025-12-25

Meta-analysis of 31 placebo-controlled RCTs (n=6437) of TNF and IL-17 inhibitors in axial spondyloarthritis: treatment effect on ASAS20 declined 5% per year, driven by rising placebo response; ASDAS-based treatment effects stayed stable.

Meta-analysisn = 6,437
Perrot et al. Evaluation of the placebo and treatment effect overtime in randomised clinical trials evaluating the efficacy of biologics in axial spondyloarthritis: systematic review and meta-analysis

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.